Related Experiment Video
Updated: Aug 9, 2025

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
A Review of Systemic Hematological Manifestations and Stent Thrombosis
Rachael Biggart1, Claire Davies2, Nikhil Joshi3
1From the Bristol Haematology & Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, England.
Insights
Stent thrombosis (ST) may signal an undiagnosed hematological condition. Early specialist testing for unexplained ST is crucial for timely, condition-specific treatment and improved patient outcomes.
Area of Science:
- Cardiology and Hematology
- Thrombosis Research
Background:
- Stent thrombosis (ST) is a serious complication of percutaneous coronary intervention (PCI), associated with high morbidity and mortality.
- Identifying non-procedural predictors of ST is challenging due to its rarity.
- Case reports suggest associations between ST and various hematological conditions, both benign and malignant.
Purpose of the Study:
- To review the literature on stent thrombosis in acquired thrombophilias.
- To highlight the importance of considering hematological conditions in unexplained ST.
- To discuss the management complexities at the intersection of cardiology and hematology.
Main Methods:
- Literature review of stent thrombosis in acquired thrombophilias.
- Case presentation of ST in paroxysmal nocturnal hemoglobinuria (PNH).
- Discussion of inherited thrombophilias and testing pitfalls.
Main Results:
- ST can be an early indicator of undiagnosed hematological disorders like PNH, myeloproliferative disorders (MPNs), antiphospholipid syndrome, hematological malignancies, and heparin-induced thrombocytopenia (HIT).
- Variability exists in clinical practice for managing ST in these complex cases.
- Multidisciplinary collaboration between cardiologists and hematologists is essential.
Conclusions:
- Unexplained stent thrombosis warrants consideration for specialist hematological evaluation.
- Prompt diagnosis and condition-specific treatment can improve outcomes for patients with ST and underlying hematological conditions.
- Integrated cardiac-hematology care is vital for optimizing ST management.
Abstract:
Stent thrombosis (ST) has significant morbidity and mortality following percutaneous coronary intervention (PCI). ST is uncommon making the identification of nonprocedural predictors challenging. Numerous case reports of ST in both benign and malignant hematological conditions exist. Given ST could be a Herald event of an undiagnosed condition and condition-specific treatment may be available, it is important to consider specialist testing in an unexplained ST. This review included a case presentation of ST in previously undiagnosed paroxysmal nocturnal hemoglobinuria (PNH) and a literature review of ST in other acquired thrombophilias including myeloproliferative disorders (MPNs), antiphospholipid syndrome, hematological malignancies, and heparin-induced thrombocytopenia (HIT). Inherited thrombophilias and common pitfalls in thrombophilia and coagulation testing are also discussed. The cardiac-hematology landscape is becoming increasingly complex and there is a paucity of how to best manage ST in these patients. There is clear variability in practice and the use of multidisciplinary input between cardiologists and hematologists is essential.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

